Despite more than two decades of advances in diagnostic criteria and technology, symptoms of Alzheimer’s disease and Related Dementias (ADRD) too often go unrecognized or are misattributed, causing delays in appropriate diagnoses and care that are both harmful and costly.
The post First Practice Guidelines for Clinical Evaluation of Alzheimer’s Disease appeared first on HealthcareNOWradio.com.